🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized open comparative parallel group study of the safety an...
Status
Completed
Location
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"
Start Date
2022-03-11
Trial ID
NCT06481215
This is a randomised, double-blind, three-arm, parallel group, single-dose ...
Status
Completed
Location
Biotrial Rennes
Start Date
2021-02-04
Trial ID
NCT04772274
Treatments Being Tested
The main aim of this study is to compare long-term remission in participant...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2021-12-01
Trial ID
NCT05056441
This is a randomized, double-blind, multicenter study to evaluate the effic...
Status
Completed
Location
Research Site
Start Date
2020-11-09
Trial ID
NCT04595409
Treatments Being Tested
Protocol Title: A Phase 1, first-in-human, randomized, double-blind, singl...
Status
Completed
Location
Nucleus Network
Start Date
2021-05-25
Trial ID
NCT04744363
Treatments Being Tested
This is a randomized single-blind comparative parallel group efficacy and s...
Status
Active Not Recruiting
Location
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation
Start Date
2023-07-25
Trial ID
NCT06488664
The purpose of this study is to assess the safety and effectiveness of 2 do...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01945086
Treatments Being Tested
BFI-751 is being developed by BioFactura Australia Pty Ltd as a biosimilar ...
Status
Completed
Location
Nucleus Network
Start Date
2021-04-01
Trial ID
NCT04843631
Treatments Being Tested
The study will investigate the efficacy and safety compared to placebo and ...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2022-12-07
Trial ID
NCT04305327
Treatments Being Tested
This study is designed to evaluate efficacy, safety, pharmacokinetics (PK) ...
Status
Completed
Location
Central Sooner Research
Start Date
2021-04-28
Trial ID
NCT04785326